Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Research in Veterinary Science
- Vol. 126, 131-138
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Light and Electron Microscopic Analysis of Consecutive Renal Biopsy Specimens From Leishmania-Seropositive DogsVeterinary Pathology, 2012
- LeishVet guidelines for the practical management of canine leishmaniosisParasites & Vectors, 2011
- Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the KidneysToxicologic Pathology, 2009
- Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniateResearch in Veterinary Science, 2007
- Systemic Hypertension in Dogs with Leishmaniasis: Prevalence and Clinical ConsequencesJournal of Veterinary Internal Medicine, 2006
- SDS-PAGE and Western blot of urinary proteins in dogs with leishmaniasisVeterinary Research, 2003
- Urinary protein/creatinine ratio in the evaluation of renal failure in canine leishmaniasis1995
- Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasisResearch in Veterinary Science, 1995
- Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dogResearch in Veterinary Science, 1994
- Renal Involvement in Canine LeishmaniasisNephron, 1991